16 C
London
Friday, October 18, 2024
HomeTagsEisai

Tag: Eisai

spot_imgspot_img

Japan – Eisai Commences Business Activities At New Pharma Sales Subsidiary In Saudi Arabia

Eisai Commences Business Activities At New Pharma Sales Subsidiary In Saudi ArabiaEisai Co., Ltd. announced today that fully-fledged operations and business activities have begun...

Japan – Eisai Announces Status Relating to Acquisition of Own Shares

Eisai Co., Ltd. announced today that it has acquired its own shares based on Article 40 of its Articles of Incorporation pursuant to the...

Japan – Eisai Named to List of The Time 100 Most Influential Companies

TIME reveals the TIME100 Most Influential Companies list, highlighting companies making an extraordinary impact around the world. To assemble the list, TIME solicited nominations...

Japan – Eisai Strengthens Venture Investment Business Aimed at Accelerating Drug Discovery Innovation and Establishment of Ecosystem Platform

Eisai Co., Ltd. announced today that the company decided to strengthen and continue its venture investment business, which launched in 2019, with the aim...

Japan – Eisai Showcases Oncology Portfolio and Pipeline at ASCO 2024

Eisai Showcases Oncology Portfolio and Pipeline at ASCO 2024 ...

Japan – Eisai: Metoject Subcutaneous Injection Pen (Methotrexate) Pen-Type Autoinjector Launched In Japan

Eisai Co., Ltd. and nippon medac Co., Ltd., a subsidiary of medac group announced today that they have launched the anti-rheumatic agent “Metoject® Subcutaneous...

Japan – Eisai: Research on Treatments for Alzheimer’s Disease Based on Its Pathological Mechanisms Recieves Award for Science and Technology (Research Category)

Eisai Co., Ltd. announced today that “The Research on Treatments for Alzheimer’s Disease Based on its Pathological Mechanisms” has received the Award for Science...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

spot_img